Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
Ann C. Skulas‐Ray, Peter W.F. Wilson, William S. Harris, et al.
Circulation (2019) Vol. 140, Iss. 12
Open Access | Times Cited: 386

Showing 1-25 of 386 citing articles:

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Henry N. Ginsberg, Chris J. Packard, M. John Chapman, et al.
European Heart Journal (2021) Vol. 42, Iss. 47, pp. 4791-4806
Open Access | Times Cited: 524
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Asmaa Abdelhamid, Tracey Brown, Julii Brainard, et al.
Cochrane library (2018)
Open Access | Times Cited: 518
Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020
Jacqueline K. Innes, Philip C. Calder
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1362-1362
Open Access | Times Cited: 303
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Asmaa Abdelhamid, Tracey Brown, Julii Brainard, et al.
Cochrane library (2020) Vol. 2020, Iss. 3
Open Access | Times Cited: 260
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting
Josefin Soppert, Michael Lehrke, Nikolaus Marx, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 4-33
Open Access | Times Cited: 249
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction
Are A. Kalstad, Peder L. Myhre, K Laake, et al.
Circulation (2020) Vol. 143, Iss. 6, pp. 528-539
Open Access | Times Cited: 239
Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
Safi U. Khan, Ahmad Naeem Lone, Muhammad Shahzeb Khan, et al.
EClinicalMedicine (2021) Vol. 38, pp. 100997-100997
Open Access | Times Cited: 239
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia
Salim S. Virani, Pamela B. Morris, Anandita Agarwala, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 9, pp. 960-993
Open Access | Times Cited: 204
The Anti-Inflammatory and Antioxidant Properties of n-3 PUFAs: Their Role in Cardiovascular Protection
Francesca Oppedisano, Roberta Macrì, Micaela Gliozzi, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 306-306
Open Access | Times Cited: 203
Causes and Consequences of Hypertriglyceridemia
Chris J. Packard, Jan Borén, Marja‐Riitta Taskinen
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 186
Effect of Omega-3 Dosage on Cardiovascular Outcomes
Aldo Bernasconi, Michelle M. Wiest, Carl J. Lavie, et al.
Mayo Clinic Proceedings (2020) Vol. 96, Iss. 2, pp. 304-313
Open Access | Times Cited: 179
Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases
Matthias B. Schulze, Anne Marie Minihane, Rasha N.M. Saleh, et al.
The Lancet Diabetes & Endocrinology (2020) Vol. 8, Iss. 11, pp. 915-930
Closed Access | Times Cited: 144
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
Tomonori Okamura, Kazuhisa Tsukamoto, Hidenori Arai, et al.
Journal of Atherosclerosis and Thrombosis (2023) Vol. 31, Iss. 6, pp. 641-853
Open Access | Times Cited: 134
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
Gerald F. Watts, Samuel S. Gidding, Robert A. Hegele, et al.
Nature Reviews Cardiology (2023) Vol. 20, Iss. 12, pp. 845-869
Open Access | Times Cited: 126
Futuristic food fortification with a balanced ratio of dietary ω-3/ω-6 omega fatty acids for the prevention of lifestyle diseases
Alok Patel, Sneha Sawant Desai, Varsha Kelkar Mane, et al.
Trends in Food Science & Technology (2022) Vol. 120, pp. 140-153
Open Access | Times Cited: 91
Impact of α-Linolenic Acid, the Vegetable ω-3 Fatty Acid, on Cardiovascular Disease and Cognition
Aleix Sala‐Vila, Jennifer Fleming, Penny M. Kris‐Etherton, et al.
Advances in Nutrition (2022) Vol. 13, Iss. 5, pp. 1584-1602
Open Access | Times Cited: 84
2023 Chinese guideline for lipid management
Jian‐Jun Li, Shui‐Ping Zhao, Dong Zhao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 69
Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association
Carol F. Kirkpatrick, Geeta Sikand, Kristina Petersen, et al.
Journal of clinical lipidology (2023) Vol. 17, Iss. 4, pp. 428-451
Open Access | Times Cited: 47
Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health
Ivana Djuričić, Philip C. Calder
The Annual Review of Pharmacology and Toxicology (2023) Vol. 63, Iss. 1, pp. 383-406
Open Access | Times Cited: 45
The Role of α-Linolenic Acid and Its Oxylipins in Human Cardiovascular Diseases
Lucia Cambiaggi, Akash Chakravarty, Nazek Noureddine, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6110-6110
Open Access | Times Cited: 41
Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use
Anna Worthmann, Julius Ridder, Sharlaine Piel, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Current Approaches to Food Waste Valorization for Nutraceuticals
Ngoc Vu
(2025), pp. 307-338
Closed Access | Times Cited: 2
REDUCE-IT USA
Deepak L. Bhatt, Michael Miller, Eliot A. Brinton, et al.
Circulation (2019) Vol. 141, Iss. 5, pp. 367-375
Open Access | Times Cited: 120
High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation
Katharina Lechner, Amy L. McKenzie, Nicolle Kränkel, et al.
Metabolic Syndrome and Related Disorders (2020) Vol. 18, Iss. 4, pp. 176-185
Open Access | Times Cited: 114
Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis
Cheng-Han Lee, Yun Fu, Shih‐Jyun Yang, et al.
Nutrients (2020) Vol. 12, Iss. 9, pp. 2769-2769
Open Access | Times Cited: 108
Page 1 - Next Page

Scroll to top